Schrumpf E, Fausa O, Førre O, Dobloug J H, Ritland S, Thorsby E
Scand J Gastroenterol. 1982 Mar;17(2):187-91. doi: 10.3109/00365528209182038.
Serologic HLA typing was carried out in 20 patients with ulcerative colitis (UC) combined with hepatobiliary disease, in 34 UC patients without hepatobiliary disease, and in control subjects. Association with HLA-B8 and -DR3 was found in both groups of patients. HLA-B8 was found in 80% of patients with combined disease (p less than 0.0005 vs. controls; relative risk (RR), 12.0), whereas 32% of the patients with UC without hepatobiliary disease were HLA-B8-positive (not significant vs. controls). Concomitantly, HLA-DR3 was found in 70% of patients with combined UC and hepatobiliary disease (p less than 0.0005 vs. controls; RR 9.95) and in 35% of UC patients without hepatobiliary disease (p less than 0.05 vs. controls; RR, 2.33). HLA-B8 was found more frequently in UC patients with than without hepatobiliary disease (p less than 0.001; RR, 8.36), as was the case with HLA-DR3 (p less than 0.025; RR, 4.28). No indications of defects in immunoregulatory lymphocytes (T gamma and T mu cells) which could explain hyperactivity in the immune system were observed in the patients with combined UC and hepatobiliary disease. The present study gives support to the theory that UC and, particularly, UC combined with hepatobiliary lesion may be autoimmune diseases with a genetic predisposition.
对20例溃疡性结肠炎(UC)合并肝胆疾病患者、34例无肝胆疾病的UC患者及对照组进行了血清学HLA分型。在两组患者中均发现与HLA - B8和 - DR3相关。80%的合并疾病患者检测到HLA - B8(与对照组相比,p<0.0005;相对风险(RR)为12.0),而无肝胆疾病的UC患者中32%为HLA - B8阳性(与对照组相比无显著性差异)。同时,70%的UC合并肝胆疾病患者检测到HLA - DR3(与对照组相比,p<0.0005;RR为9.95),无肝胆疾病的UC患者中35%检测到HLA - DR3(与对照组相比,p<0.05;RR为2.33)。与无肝胆疾病的UC患者相比,HLA - B8在合并肝胆疾病的UC患者中更常见(p<0.001;RR为8.36),HLA - DR3情况相同(p<0.025;RR为4.28)。在UC合并肝胆疾病患者中未观察到免疫调节淋巴细胞(Tγ和Tμ细胞)缺陷的迹象,而这种缺陷可能解释免疫系统的过度活跃。本研究支持UC,尤其是合并肝胆病变的UC可能是具有遗传易感性的自身免疫性疾病这一理论。